Stock 300871 HVSEN BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hvsen Biotechnology Co., Ltd.

Equities

300871

CNE1000047H6

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
14.43 CNY -0.62% Intraday chart for Hvsen Biotechnology Co., Ltd. -6.78% -0.21%
May. 23 Hvsen Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024 CI
Apr. 25 Hvsen Biotechnology Co., Ltd. Proposes Final Cash Dividend for 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 4,735 3,356 2,364 2,359 - -
Enterprise Value (EV) 1 4,735 3,356 2,364 2,359 2,359 2,359
P/E ratio 35.6 x 64 x 143 x 35.6 x 17.6 x 18.7 x
Yield - 1.47% 1.87% 2.7% 4.57% 6.93%
Capitalization / Revenue - 3.28 x 2.32 x 1.89 x 1.51 x 1.31 x
EV / Revenue - 3.28 x 2.32 x 1.89 x 1.51 x 1.31 x
EV / EBITDA - 27.6 x - 10.5 x 8.02 x 6.29 x
EV / FCF - -10.1 x -25.9 x -29.9 x 20.3 x 10.4 x
FCF Yield - -9.89% -3.87% -3.35% 4.92% 9.62%
Price to Book - 2.39 x 1.74 x 1.53 x 1.45 x 1.4 x
Nbr of stocks (in thousands) 166,249 164,531 163,498 163,498 - -
Reference price 2 28.48 20.40 14.46 14.43 14.43 14.43
Announcement Date 3/10/22 4/26/23 4/24/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - 1,023 1,020 1,246 1,566 1,800
EBITDA 1 - 121.7 - 225 294 375
EBIT 1 - 59.16 15.08 69 133.5 128
Operating Margin - 5.78% 1.48% 5.54% 8.53% 7.11%
Earnings before Tax (EBT) 1 - 56.71 12.44 68 132 127
Net income 1 132.9 52.71 16.78 67.5 136.5 128
Net margin - 5.15% 1.65% 5.42% 8.72% 7.11%
EPS 2 0.8000 0.3186 0.1011 0.4050 0.8200 0.7700
Free Cash Flow 1 - -332.1 -91.39 -79 116 227
FCF margin - -32.47% -8.96% -6.34% 7.41% 12.61%
FCF Conversion (EBITDA) - - - - 39.46% 60.53%
FCF Conversion (Net income) - - - - 84.98% 177.34%
Dividend per Share 2 - 0.3000 0.2700 0.3900 0.6600 1.000
Announcement Date 3/10/22 4/26/23 4/24/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - -332 -91.4 -79 116 227
ROE (net income / shareholders' equity) - 3.36% 1.1% 4.33% 8.25% 7.52%
ROA (Net income/ Total Assets) - 1.84% - 2.29% 3.69% 5.27%
Assets 1 - 2,865 - 2,948 3,699 2,429
Book Value Per Share 2 - 8.520 8.330 9.430 9.960 10.30
Cash Flow per Share 2 - 0.5800 - 1.610 1.420 1.760
Capex 1 - 429 184 179 109 100
Capex / Sales - 41.92% 18.07% 14.37% 6.93% 5.55%
Announcement Date 3/10/22 4/26/23 4/24/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Hvsen Biotechnology Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
14.43
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Veterinary Drugs

1st Jan change Capi.
HVSEN BIOTECHNOLOGY CO., LTD. Stock Hvsen Biotechnology Co., Ltd.
-0.21% 326M
ZOETIS INC. Stock Zoetis Inc.
-13.83% 77.6B
ELANCO ANIMAL HEALTH INCORPORATED Stock Elanco Animal Health Incorporated
+12.68% 8.3B
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+24.00% 3.67B
VIRBAC Stock Virbac
+0.14% 3.27B
VIMIAN GROUP AB Stock Vimian Group AB
+14.70% 1.67B
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-4.46% 1.59B
VETOQUINOL SA Stock Vetoquinol SA
+2.54% 1.35B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-22.01% 1.3B
WUHAN KEQIAN BIOLOGY CO.,LTD Stock Wuhan Keqian Biology Co.,Ltd
-12.12% 1.15B
Veterinary Drugs
  1. Stock Market
  2. Equities
  3. 300871 Stock
  4. Financials Hvsen Biotechnology Co., Ltd.